{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:55:55Z","timestamp":1791028555847,"version":"4.1.0"},"reference-count":27,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1507\/endocrj.k07-034","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T01:48:17Z","timestamp":1203990497000},"page":"953-959","source":"Crossref","is-referenced-by-count":27,"title":["The Relationship between Serum Levels of Estradiol and Osteoprotegerin in Patients with Anorexia Nervosa"],"prefix":"10.1507","volume":"54","author":[{"given":"Rina","family":"OHWADA","sequence":"first","affiliation":[{"name":"Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"HOTTA","sequence":"additional","affiliation":[{"name":"Health Services Center, National Graduate Institute for Policy Studies"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"SATO","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"SHIBASAKI","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"TAKANO","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mehler S (2003) Osteoporisis in anorexia nervosa: Prevention and treatment. Int J Eat Disord 33: 113-126.","DOI":"10.1002\/eat.10119"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mistra M, Klibanski A (2002) Evaluation and treatment of low bone density in anorexia nervosa. Nutr Clin Care 5\/6: 298-308.","DOI":"10.1046\/j.1523-5408.2002.05605.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470275"},{"issue":"3","key":"4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1530\/eje.0.1390276","volume":"139","author":"HOTTA M","year":"1998","ISSN":"https:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.1.200"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Heer M, Mika C, Grzella I, Drummer C, Herpertz-Dahlmann (2002) Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment. Clinical Chemistry 48: 754-760.","DOI":"10.1093\/clinchem\/48.5.754"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Bonnet T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 18: 309-319.","DOI":"10.1016\/S0092-8674(00)80209-3"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"9","unstructured":"9. Yasuda H, Shima N, Yamaguchi N, Kinosaki M, Mochizuki S, Yano K, Goto M, Tsuda A, Morinaga T, Higashio K, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor identical to TRANCE\/RANKL. Cell Biology 95: 3597-3602."},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.9.4367"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saika M, Inoue D, Kibo S, Matsumoto T (2001) 17 beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 142: 2205-2012.","DOI":"10.1210\/endo.142.6.8220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bord S, Ireland DC, Beavan SR, Compston JE (2003) The effect of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. BONE 32: 136-141.","DOI":"10.1016\/S8756-3282(02)00953-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liao EY, Luo XH, Su X (2002) Comparison of the effects of 17&beta;-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast like cells. J Endocrinol Invest 25: 785-790.","DOI":"10.1007\/BF03345513"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317215"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo E, Marini R, Inferrera M, Marini H, Bitto A, D'anna R, Corrado F, Bartolone S, Frisina N, Squadrito F (2004) Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor &kappa;B ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 89: 188-192.","DOI":"10.1210\/jc.2003-030891"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Misra M, Soyka L, Miller K, Herzog D, Grinspoon S, Chen D, Neubauer G, Klibanski A (2003) Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 88: 3816-3822.","DOI":"10.1210\/jc.2003-030088"},{"key":"17","unstructured":"17. Kahl K, Rudolf S, Dibbelr L, Stoeckelhuber B, Gehl H, Hohagen F, Schweiger U (2004) Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. Osteoporosis International 10.1007: 1711-1715."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jung K, Lein M, Hosslin K, Grosse A, Roth S, Possinger K, Luftner D (2002) Osteoprotegerin and receptor activator of nuclear factor-&kappa;B ligand (RANKL) in the serum of healthy adults. Int J Biol Markers 17: 177-181.","DOI":"10.1177\/172460080201700306"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hofbauer LC, Scoppet M, Schuller P, Viereckt V, Chist M (2004) Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. Clin Endocrinol 60: 214-219.","DOI":"10.1046\/j.1365-2265.2003.01969.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Buzi F, Maccarinelli G, Guaragni B, Ruggeri F, Radetti G, Meini A, Mazzolari E, Cocchi D (2003) Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turners' syndrome and rheumatoid arthritis. Clin Endocrinol (Oxf) 60: 87-91.","DOI":"10.1111\/j.1365-2265.2004.01951.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rubin J, Ackert-Bicknell CL, Zhu L, Fan X, Murphy TC, Names MS, Marcus R, Holloway L, Beamer WG, Rosen CJ (2002) IGF-1 regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-&kappa;B ligand <i>in vitro <\/i>and OPG<i> in vivo.<\/i> J Clin Endocrinol Metab 87: 4273-4279.","DOI":"10.1210\/jc.2002-020656"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ueland T, Odgren PR, Yndestad A, Godang K, Schreiner T, Marks SC, Bollerslev J (2003) Growth hormone substitution increases gene expression of members of the IGF family in cortical bome from women with adult onset growth hormone deficiency-relationship with bone turn-over. BONE 33: 638-645.","DOI":"10.1016\/S8756-3282(03)00240-0"},{"key":"23","unstructured":"23. Grigorie D, Neacsu E, Marinescu M, Popa O (2004) Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. Rom J Intern Med 41: 409-415."},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.2.200"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Thomas T, Burguera B (2002) Is leptin the link between fat and bone mass? J Bone Miner Res 17: 1563-1569.","DOI":"10.1359\/jbmr.2002.17.9.1563"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Buxton EC, Yao W, Lane NE (2004) Changes in rerum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab 89: 3332-3336.","DOI":"10.1210\/jc.2003-032066"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Seck T, Diel I, Bismar H, Zeigler R, Pfeilschifter J (2001) Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples. Eur J Endocrinol 145: 199-205.","DOI":"10.1530\/eje.0.1450199"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/6\/54_K07-034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:45:13Z","timestamp":1618296313000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/6\/54_K07-034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k07-034","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}